Advertisement
UK markets close in 4 hours 56 minutes
  • FTSE 100

    8,168.57
    -46.91 (-0.57%)
     
  • FTSE 250

    20,347.78
    -149.62 (-0.73%)
     
  • AIM

    785.82
    -1.54 (-0.20%)
     
  • GBP/EUR

    1.1831
    -0.0002 (-0.02%)
     
  • GBP/USD

    1.2784
    -0.0016 (-0.12%)
     
  • Bitcoin GBP

    52,698.06
    -347.53 (-0.66%)
     
  • CMC Crypto 200

    1,415.83
    +2.88 (+0.20%)
     
  • S&P 500

    5,421.03
    +45.71 (+0.85%)
     
  • DOW

    38,712.21
    -35.21 (-0.09%)
     
  • CRUDE OIL

    77.71
    -0.79 (-1.01%)
     
  • GOLD FUTURES

    2,335.00
    -19.80 (-0.84%)
     
  • NIKKEI 225

    38,720.47
    -156.24 (-0.40%)
     
  • HANG SENG

    18,112.63
    +174.79 (+0.97%)
     
  • DAX

    18,392.44
    -238.42 (-1.28%)
     
  • CAC 40

    7,755.64
    -109.06 (-1.39%)
     

Eastman Chemical Company (NYSE:EMN) is a favorite amongst institutional investors who own 85%

Key Insights

  • Institutions' substantial holdings in Eastman Chemical implies that they have significant influence over the company's share price

  • 51% of the business is held by the top 15 shareholders

  • Recent sales by insiders

To get a sense of who is truly in control of Eastman Chemical Company (NYSE:EMN), it is important to understand the ownership structure of the business. With 85% stake, institutions possess the maximum shares in the company. Put another way, the group faces the maximum upside potential (or downside risk).

Given the vast amount of money and research capacities at their disposal, institutional ownership tends to carry a lot of weight, especially with individual investors. Therefore, a good portion of institutional money invested in the company is usually a huge vote of confidence on its future.

ADVERTISEMENT

In the chart below, we zoom in on the different ownership groups of Eastman Chemical.

Check out our latest analysis for Eastman Chemical

ownership-breakdown
ownership-breakdown

What Does The Institutional Ownership Tell Us About Eastman Chemical?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

As you can see, institutional investors have a fair amount of stake in Eastman Chemical. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Eastman Chemical's historic earnings and revenue below, but keep in mind there's always more to the story.

earnings-and-revenue-growth
earnings-and-revenue-growth

Institutional investors own over 50% of the company, so together than can probably strongly influence board decisions. Hedge funds don't have many shares in Eastman Chemical. Looking at our data, we can see that the largest shareholder is The Vanguard Group, Inc. with 13% of shares outstanding. For context, the second largest shareholder holds about 7.5% of the shares outstanding, followed by an ownership of 7.2% by the third-largest shareholder.

A closer look at our ownership figures suggests that the top 15 shareholders have a combined ownership of 51% implying that no single shareholder has a majority.

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. Quite a few analysts cover the stock, so you could look into forecast growth quite easily.

Insider Ownership Of Eastman Chemical

While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

Our data suggests that insiders own under 1% of Eastman Chemical Company in their own names. As it is a large company, we'd only expect insiders to own a small percentage of it. But it's worth noting that they own US$59m worth of shares. It is good to see board members owning shares, but it might be worth checking if those insiders have been buying.

General Public Ownership

The general public-- including retail investors -- own 14% stake in the company, and hence can't easily be ignored. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

Next Steps:

It's always worth thinking about the different groups who own shares in a company. But to understand Eastman Chemical better, we need to consider many other factors. Consider for instance, the ever-present spectre of investment risk. We've identified 3 warning signs with Eastman Chemical (at least 1 which is a bit concerning) , and understanding them should be part of your investment process.

Ultimately the future is most important. You can access this free report on analyst forecasts for the company.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here